These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15590454)

  • 1. Placental growth hormone in Down's syndrome screening.
    Baviera G; Carbone C; Corrado F; Mastrantonio P
    J Matern Fetal Neonatal Med; 2004 Oct; 16(4):241-3. PubMed ID: 15590454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Fetal Diagn Ther; 2008; 23(3):211-6. PubMed ID: 18417980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum markers for Down's syndrome pregnancies.
    Chew S; Anandakumar C; Ratnam SS
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated measures screening for Down's Syndrome.
    Wright DE; Bradbury I
    BJOG; 2005 Jan; 112(1):80-3. PubMed ID: 15663402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated screening for Down's syndrome.
    Chen FM
    J Fam Pract; 1999 Nov; 48(11):846-7. PubMed ID: 10907617
    [No Abstract]   [Full Text] [Related]  

  • 13. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
    Morris JK; Bestwick J; Wald NJ
    J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome.
    Christiansen M
    Prenat Diagn; 2009 Dec; 29(13):1249-55. PubMed ID: 19844941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
    Weisz B; Rodeck CH
    Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter-Knill-Jones (S-KJ) approach.
    Hwa HL; Yen MF; Hsieh FJ; Ko TM; Chen TH
    J Perinat Med; 2004; 32(5):407-12. PubMed ID: 15493716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum müllerian-inhibiting substance in Down's syndrome pregnancies.
    Seifer DB; MacLaughlin DT; Cuckle HS
    Hum Reprod; 2007 Apr; 22(4):1017-20. PubMed ID: 17218369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.